Clinical Trial Update: ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether adding androgen deprivation therapy (ADT) to SBRT improves outcomes versus SBRT alone in unfavorable intermediate-risk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: NYU Langone Health | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING